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Introduction
Most common diseases result from the 
combined effect of genes and environ-
mental factors and the interactions between 
them. Epigenetic effects and non-coding 
gene products have gained research focus 
over the last two decades because protein-
coding genes cannot account for al l 
observed genomic effects. Here we focus on 
microRNAs (miRNAs) as key regulators of 
health and disease. miRNAs are endogenous, 
single-stranded, short non-coding RNA 
sequences (~ 22 nucleotides) that regulate 
gene expression at the post transcriptional 
level. Since the first discovery of miRNAs 
in Caenorhabditis elegans (Lee et al. 1993), 
hundreds of miRNAs in eukaryotes have been 
identified to influence physio logical processes 
such as development, growth, differentiation, 
immune reaction, and adaptation to stress 
(van Rooij et al. 2007; Xiao et al. 2007). 
Diverse disease states, such as cancer and 
heart failure, are associated with distinct 
miRNA signatures, suggesting that specific 
miRNA programs are activated in patho-
physiological processes (Calin et al. 2005).
Recent advances in molecular biology 
opened the opportunity for new approaches 
in population-based studies, in which 
exposures to a broad spectrum of environ-
mental pollutants are evaluated in concert 
with biological systems, a concept proposed as 
the “exposome” (Wild 2005). From this view-
point, miRNAs could potentially be novel 
biomarkers of exposure. For the purpose of 
this review, we focused on the response of 
miRNAs to environmental exposures.
miRNA characteristics. miRNA-mediated 
gene silencing is accomplished by base 
pairing of the 5´ region of miRNAs with the 
target mRNA sequence, leading to transla-
tional repression and/or mRNA degradation 
(Ambros 2004). miRNAs have been para-
doxically shown to up-regulate gene expres-
sion by enhancing translation under specific 
conditions (Vasudevan et al. 2007). The 
effect of miRNA expression on gene expres-
sion is not linear, as multiple miRNAs may 
target the same mRNA, and the majority of 
mRNAs contain multiple binding sites for 
miRNAs, generating a highly complex regula-
tory network system (Saetrom et al. 2007). 
For details on miRNA synthesis, biogenesis, 
miRNA mechanism of action, see Figure 1 
and reviews by Djuranovic et al. (2011) and 
Murchison and Hannon (2004).
miRNA nomenclature. miRNAs are 
named using the “miR” prefix and a unique 
identifying number (e.g., miR-1, miR-2). The 
identifying numbers are assigned sequentially, 
with identical miRNAs having the same 
number, regardless of organism. Paralogous 
sequences whose mature miRNAs differ at 
only one or two positions are given lettered 
suffixes: for example, miR-10a and miR-10b. 
Distinct hairpin loci that give rise to identical 
mature miRNAs have numbered suffixes (e.g., 
mir-281-1, mir-281-2). The mature sequences 
are designated “miR,” whereas the precursor 
hairpins are labeled “mir.” The -3p and -5p 
suffixes that sometimes appear within an 
miR name refer to the arm from which the 
mature sequence comes. For nomenclature 
guidelines, see Ambros et al. (2003).
miRNA analysis techniques suitable 
for large epidemiological studies. In recent 
years, miRNA expression changes following 
exposure to environmental toxicants, even 
before disease onset, have gained researchers’ 
interest. The measure of miRNAs in large 
epidemiological studies needs to be high 
throughput and sensitive enough to detect 
small changes in healthy subjects. At the 
same time, techniques need to be affordable 
in order to be conducted in large popula-
tion studies. Moreover, given the complexity 
of phenomena induced by exposure but 
not fully explained by an effect on a single 
transcript, current research is going toward 
genome-wide techniques. Another chal-
lenge is tissue specificity of miRNAs: The 
availability of only non invasive samples in 
epidemiological studies conducted on 
healthy populations limits our capability to 
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Background: The exposome encompasses all life-course environmental exposures from the prenatal 
period onward that influence health. MicroRNAs (miRNAs) are interesting entities within this 
concept as markers and causation of disease. MicroRNAs are short oligonucleotide sequences that 
can interact with several mRNA targets.
oBjectives: We reviewed the current state of the field on the potential of using miRNAs as 
biomarkers for environmental exposure. We investigated miRNA signatures in response to all 
types of environmental exposure to which a human can be exposed, including cigarette smoke, air 
pollution, nanoparticles, and diverse chemicals; and we examined the health conditions for which the 
identified miRNAs have been reported (i.e., cardiovascular disease, cancer, and diabetes). 
Methods: We searched the PubMed and ScienceDirect databases to identify relevant studies.
results: For all exposures incorporated in this review, 27 miRNAs were differentially expressed in 
at least two independent studies. miRNAs that had expression alterations associated with smoking 
observed in multiple studies are miR-21, miR-34b, miR-125b, miR-146a, miR-223, and miR-340; 
and those miRNAs that were observed in multiple air pollution studies are miR-9, miR-10b, 
miR-21, miR-128, miR-143, miR-155, miR-222, miR-223, and miR-338. We found little overlap 
among in vitro, in vivo, and human studies between miRNAs and exposure. Here, we report on 
disease associations for those miRNAs identified in multiple studies on exposure.
conclusions: miRNA changes may be sensitive indicators of the effects of acute and chronic environ-
mental exposure. Therefore, miRNAs are valuable novel biomarkers for exposure. Further studies 
should elucidate the role of the mediation effect of miRNA between exposures and effect through all 
stages of life to provide a more accurate assessment of the consequences of miRNA changes.
citation: Vrijens K, Bollati V, Nawrot TS. 2015. MicroRNAs as potential signatures of environ-
mental exposure or effect: a systematic review. Environ Health Perspect 123:399–411; http://
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investigate target tissues and opens important 
questions on the meaning of those markers 
in surrogate tissues. In epidemiological 
research, free and exosomal miRNAs in body 
fluids are interesting study objects because 
of their potential to serve as a proxy for 
tissue-specific miRNAs. A limitation of this 
approach is that these miRNAs differ between 
different body fluids, and their function is 
not clear. Although miRNAs hold promise 
as exposure biomarkers, recent studies have 
been primarily disease focused [reviewed by 
Etheridge et al. (2011)].
Genome-wide miRNA analysis can be 
achieved by amplification-based [real-time 
quantitative reverse-transcriptase polymerase 
chain reaction (qRT-PCR)], hybridization-
based (micro arrays), and sequencing-based 
[next-generation sequencing (NGS)] tech-
nologies. Method selection depends on the 
type of sample to be analyzed and the RNA 
preparation protocol used. qRT-PCR is 
considered the gold standard because of its 
sensitivity, specificity, accuracy, and simple 
protocols. qRT-PCR can evaluate candidate 
miRNA expression or array plates that include 
a large number of miRNAs in one reaction, 
to OpenArray® (Applied Biosystems, Life 
Technologies), which allows the simultaneous 
amplification of a very large panel of miRNAs 
using nanoscale volumes. In a recent review, 
Prokopec et al. (2013) compared qRT-PCR to 
different array-based platforms used to study 
mRNAs/miRNAs. 
Several miRNA microarray chip plat-
forms that are commercially available [e.g., 
Affymetrix GeneChip® 3.0 miRNA array 
(Affymetrix Inc.), Agilent Human miRNA 
Microarray system (Agilent Technologies), 
Exiqon miRCURY LNA™ microarray 
(Exiqon Inc.)] differ in probe design and 
detection stringency. The limitation of this 
micro array chip method is the availability and 
stringency of probes on the chip platform that 
pair with miRNAs of interest. Microarrays 
have the advantage of being easily correlated 
to mRNA expression data, thus providing 
functional information. Furthermore, 
unlike other current miRNA analysis tech-
niques, micro arrays allow fast analysis of 
miRNAs without an arbitrary pre selection 
step. However, the large amount of data 
produced can generate false-positive results, 
and the time-consuming step of validation by 
qRT-PCR is almost necessary. 
NGS strategies based on deep sequencing 
overcome some of the technical drawbacks 
of probe-based methodologies, especially 
the ability to detect only previously known 
sequences (Schulte et al. 2010). As miRNAs 
are sequenced directly, information about 
sequence variations or post transcriptional RNA 
editing becomes available for further analysis. 
The newly developed Nanostring nCounter 
27 (Nanostring Technologies Inc.) uses two 
sequence-specific capture probes to allow 
for discrimination between similar variants 
of a single miRNA. NGS technologies [e.g., 
Illumina/Solexa (Illumina Inc.), GA Roche/454 
GS FLX Titanium (Roche Diagnostics Corp.), 
and ABI/SOLID (Applied Biosystems)] allow 
complete “miRnomes” to be sequenced and 
allow for the discovery of novel miRNAs and 
isoforms. Another benefit of NGS technology 
Figure 1. Overview of miRNA biogenesis. The canonical maturation of a miRNA includes the production 
of the primary miRNA transcript (pri-miRNA) by RNA polymerase II or III (Pol II/III) and cleavage of the 
pri-miRNA by the microprocessor complex Drosha–DGCR8 (Pasha) in the nucleus. The resulting precursor 
hairpin, the pre-miRNA, is exported from the nucleus by Exportin-5–Ran-GTP. In the cytoplasm, the RNase 
Dicer in complex with the double-stranded RNA-binding protein TRBP cleaves the pre-miRNA hairpin to 
its mature length. The functional strand of the mature miRNA is loaded together with Argonaute (Ago2) 
proteins into the RNA-induced silencing complex (RISC), where it guides RISC to silence target mRNAs 
through mRNA cleavage, translational repression, or deadenylation, whereas the passenger strand (black) 
is degraded. 
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Figure 2. Flowchart of included studies.
109 papers 
187 references identified in PubMed and 
ScienceDirect using the search terms 
“microRNA” and “environmental exposure”
128 additionally identified in 
PubMed and ScienceDirect using 
the search term “microRNA” in
combination with key terms
“smoking” (115), “passive smoking”
(2), or “cigarette smoke” (11)
6 articles added from PubMed and
ScienceDirect using the search
terms “microRNA” and “air pollution”
23 publications added from PubMed 
and ScienceDirect using the search 
terms “microRNA” combined with 
key terms “bisphenol A” (6), 
“endocrine disruptors” (2), or 
”chemical exposure” (15)
235 publications excluded
105 reviews
3 letters to the editor, editorials
16 methodological papers
5 conference proceedings
48 studies in nonmammalian species
58 studies that did not correlate
environmental exposure to 
microRNA expression
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is that it can identify precursor and primary 
miRNAs as well as their mature forms. 
NGS will likely become the gold standard 
for miRNA analysis because of its ability to 
sequence short fragments in a high-throughput 
mode. The choice between these methods is 
a key factor in establishing the possibility of 
success of any epidemiological study. Each 
method has pros and cons and should be evalu-
ated based on the specific research.
Methods
Search strategy and selection criteria. To 
identify the articles relevant to this topic, we 
undertook a comprehensive search of the 
PubMed (http://www.ncbi.nlm.nih.gov/
pubmed) and ScienceDirect (http://www.
sciencedirect.com/) databases initially using 
“microRNA” and “environmental exposure” 
as key terms. We did additional searches in 
which we replaced “microRNA” with “mir,” 
“miRNA,” or “epigenetic changes” and 
we substituted “environmental exposure” 
with “smoking,” “passive smoking,” “ciga-
rette smoke,” “air pollution,” “nanoparticle 
exposure,” “bisphenol A,” “endocrine 
disruptors,” or “chemical exposure” in every 
possible combination. We also considered 
review articles as well as references found in 
our literature search. We excluded articles 
not written in English. The PubMed search 
covered 1 January 1980 to 1 June 2014. 
Articles dealing only with the description 
of single nucleotide polymorphisms (SNPs) 
in miRNA genes were disregarded, as were 
those articles dealing only with the descrip-
tion of miRNAs in non mammalian species. 
A flowchart detailing the search strategy is 
presented in Figure 2. For miRNAs differ-
entially expressed in response to more than 
one personal or environmental exposure, we 
researched disease phenotypes correlated with 
Table 1. miRNAs that are responsive to personal or environmental exposure and their roles in human disease.
miRNA Regulated Exposure Diseases Sources
Let-7e Down TCDD HCC, lung, pituitary, and breast cancer, GEP tumors Feitelson and Lee 2007; Qian et al. 2009; Rahman et al. 
2009; Sakurai et al. 2012; Takamizawa et al. 2004
Up RDX Heart failure, asthma Polikepahad et al. 2010; Thum et al. 2007
Let-7g Down BPA, PM Lung carcinoma, GEP tumors, breast cancer Rahman et al. 2009; Sakurai et al. 2012
miR-9 Down PM Brain cancer, Huntingon’s disease Ferretti et al. 2009; Lau and de Strooper 2010
Up Aluminum Hodgkin lymphoma, breast cancer Leucci et al. 2012; Ma et al. 2010
miR-10b Down Formaldehyde, PM Gastric cancer Kim K et al. 2011
miR-21 Down Smoking Diabetes type 2 Zampetaki et al. 2010
Up DEP, metal-rich PM Breast cancer, glioblastoma, neo-intimal lesions, cardiac 
hypertrophy, atherosclerosis
Ji et al 2007; Raitoharju et al. 2011; van Rooij et al. 2007; 
Volinia et al. 2006
miR-26b Down DEP, BPA, PFOA Schizophrenia, CRC, breast cancer Earle et al. 2010; Liu et al. 2011; Perkins et al. 2007
miR-31 Down DEP, TCDD Medulloblastoma, T-cell leukemia Ferretti et al. 2009; Yamagishi et al. 2012
miR-34b Down Smoking (2×) CRC, pancreatic, mammary, ovarian, and renal cell 
carcinoma
Vogt et al. 2011
miR-92b Down Smoking, DDT Medulloblastoma Genovesi et al. 2011
miR-122 Down Smoking HCC Bai et al. 2009
Up TCDD Hepatitis C, renal cell carcinoma, male infertility, sepsis, 
hyperlipidemia
Gao et al. 2012; Henke et al. 2008; Wang C et al. 2011; 
Wang H et al. 2012; White et al. 2011
miR-125b Down Smoking (2×) Breast cancer, head and neck cancer Nakanishi et al. 2014; Zhang et al. 2011
Up Aluminum sulfate (2×) Endometriosis, cardiac hypertrophy, Alzheimer’s disease Busk and Cirera 2010; Lukiw and Alexandrov 2012; 
Ohlsson Teague et al. 2009
miR-135b Down DEP Medulloblastoma Lv et al. 2012
Up Smoking CRC Nagel et al. 2008
miR-142 Down Formaldehyde Heart failure Voellenkle et al. 2010
Up Smoking B-cell ALL Ju et al. 2009
miR-143 Up PM, ozone Colon cancer Zhang et al. 2013
miR-146a Down Smoking Postpartum psychosis, type 2 diabetes Weigelt et al. 2013; Zampetaki et al. 2010
Up BPA, aluminum sulfate (2×) Alzheimer’s disease, Creutzfeldt-Jakob disease, 
atherosclerosis, leukemia, protection against 
myocardial injury
Lukiw and Alexandrov 2012; Lukiw et al. 2011; 
Raitoharju et al. 2011; Wang et al. 2013; Wang Y et al. 
2010
miR-149 Up BPA, DDT Melanoma Jin et al. 2011
miR-155 Down PM Hypertension Xu et al. 2008
Up PM Breast cancer, Hodgkin lymphoma, B-ALL Chang et al. 2011; Kong et al. 2014; Palma et al. 2014
miR-181a Down Formaldehyde Leukemia, glioma, NSCLC, breast cancer, metabolic 
syndrome, and CAD
Gao et al. 2010; Hulsmans et al. 2012; Marcucci et al. 
2008; Ota et al. 2011; Shi et al. 2008
Up TCDD Severe preeclampsia, male infertility Hu et al. 2009; Wang C et al. 2011
miR-203 Down Smoking, formaldehyde Myeloma Wong et al. 2011
miR-205 Up Smoking (2×) Heart failure, lung cancer Thum et al 2007; Yanaihara et al. 2006
miR-206 Up Smoking, RDX Myocardial infarct, slows ALS progression, myotonic 
dystrophy
Gambardella et al. 2010; Shan et al. 2009; Williams et al. 
2009
miR-222 Up Metal-rich PM, BPA Severe preeclampsia, thyroid carcinoma, prostate cancer, 
breast cancer
Hu et al. 2009; Miller et al. 2008; Pallante et al. 2006
miR-223 Down Smoking AML Eyholzer et al. 2010
Up Smoking Heart failure, atherosclerosis Greco et al. 2012; Kin et al. 2012
miR-338-5p Down Formaldehyde Melanoma Caramuta et al. 2010
Up DEP Oral carcinoma Scapoli et al. 2010
miR-340 Down Smoking NA NA
Up Smoking Heart failure, breast cancer Thum et al. 2007; Wu et al. 2011
miR-638 Up BPA, DDT, arsenic Lupus nephritis Dai et al. 2009
miR-663 Up BPA, DDT, arsenic CTCL, nasopharyngeal carcinoma, burns Liang et al. 2012; Ralfkiaer et al. 2011; Yi et al. 2012
Abbreviations: ACC, acute lymphocytic leukemia; ALS, amyotrophic lateral sclerosis; AML, acute myeloid leukemia; B-ALL, B-cell acute lymphocytic leukemia; BPA, bisphenol A; 
CAD, coronary artery disease; CRC, colorectal carcinoma; CTCL, cutaneous T-cell lymphoma; DDT, dichlorodiphenyltrichloroethane; DEP, diesel exhaust particles; GEP, gastro-
entero pancreatic; HCC, hepatocellular carcinoma; NA, not applicable; NSCLC, non-small cell lung carcinoma; PFOA, perfluorooctanoic acid; PM, particulate matter; RDX, hexahydro-
1,3,5-trinitro-s-triazine; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin.
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them by searching each of these miRNAs on 
the Human microRNA Disease Database 
(HMDD; http://202.38.126.151/hmdd/
mirna/md/) and the miR2Disease Base (http://
www.mir2disease.org/). Results of these 
searches are presented in Table 1, including 
the direction of regulation (up or down) of the 
miRNA and the ensuing phenotype.
Results
Smoking-induced changes  in miRNA 
expression. The most studied environmental 
factor in relation to epigenetics is smoking; 
it was among the first factors shown to 
affect the miRNA machinery in humans 
(Spira et al. 2004). Results of in vitro studies 
concerning smoking and miRNAs are 
summarized in Table 2.
Izzotti et al. (2009) analyzed miRNA 
expression patterns in the lungs of mice 
exposed to passive cigarette smoke, and 
they established life-course–related miRNA 
expression changes by comparing miRNA 
express ion in lungs from unexposed 
newborn, post weaning, and adult mice. 
These researchers observed developmental-
stage–specific miRNA expression profiles in 
which miRNAs that were highly expressed 
in newborns tended to be less expressed in 
adult mice and vice versa, whereas miRNA 
expression in post weaning mice was interme-
diate (Izzotti et al. 2009). Results from in vivo 
studies concerning smoking and miRNAs are 
shown in Table 3.
Two studies reported a comparison 
between mRNA and miRNA whole genome 
express ion patterns for smokers and 
non smokers (Schembri et al. 2009; Takahashi 
et al. 2013). Takahashi et al. (2013) 
reported that quitting smoking altered the 
plasma miRNA profiles to resemble those of 
non smokers. In addition, Let-7c and miR-150 
could be of importance in the initiation of 
smoke-induced decline of lung function, 
because genes that were associated with 
lung function impairment in genome-wide 
association studies have been reported to be 
significantly enriched in binding sites for these 
miRNAs, namely STAT3 (Qu et al. 2009) 
and TNFR‑II (D’hulst et al. 2006).
The effect of in utero exposures on health 
during childhood and later in life is a growing 
area of research interest with major public 
health implications (Gluckman et al. 2008). 
An adaptive response in the fetus to in utero 
exposures can result in persistent changes 
into adulthood. miRNA expression levels 
in placenta can affect health later in life 
(Maccani et al. 2011). Studies on miRNA 
expression and human exposure at different 
stages of life (in utero, adult) are included 
in Table 4.
Not surprisingly, miRNAs that are 
frequently observed to be down-regulated in 
Table 2. In vitro studies on the effects of smoking on differential miRNA expression.
miRNA miR function Regulation Tissue/cell type Source
miR-15a Tumor suppressor Down Primary bronchial epithelial cells Schembri et al. 2009
miR-125b Targets p53, stress response
miR-199b Oncogene activation
miR-218 Tumor suppressor
miR-31 Apoptosis, tumor suppressor Up Normal and cancer lung cells Xi et al. 2010
miR-21 Fatty acid synthesis, apoptosis Up Human squamous carcinoma cells Zhang et al. 2014
miR-452 Targets CDK1 Down Human alveolar macrophages Graff et al. 2012
Table 3. In vivo studies on the effects of smoking on differential miRNA expression.
miRNA miR function Regulation Tissue/cell type Source
miR-34b p53 effector Down Mouse lung Izzotti et al. 2011
miR-421 Targets SMAD4, polycomb gene CBX7, ATM 
miR-450b No validated targets
miR-466 No validated targets
miR-469 Mouse miR not validated
miR-135b Inflammation, oxidative stress Up Mouse lung Halappanavar et al. 2013
miR-206 Targets SERP1, BDNF, FOXP1 Up Rat serum Wu et al. 2013
miR-133b Targets LAG1, PTBP2
miR-20b Hypoxia Down Mouse lung and 
plasma
Huang et al. 2012
miR-30e Targets UBC9, UBE21, MUC17
miR-125b Targets p53, stress response
miR-128 Apoptosis
let-7a Cell proliferation, angiogenesis Down Mouse lung Izzotti et al. 2009
let-7b Cell proliferation, angiogenesis
let-7f Cell proliferation, angiogenesis
miR-26a Transforming growth factor expression
miR-30b Cell adhesion, stress response
miR-30c Cell cycle, oncogene activation
miR-34b p53 effector
miR-99b Apoptosis
miR-122a Stress response
miR-124a Stress response, cell growth and differentiation
miR-125a Oncogene activation, ROS
miR-125b Targets p53, stress response
miR-140 p53 effector
miR-192 Oncogene activation
miR-431 Protein repair, oncogene activation
miR-92b Tumor suppressomiR Down Mouse serum Yuchuan et al. 2014
miR-668 Inflammation
miR-700 Inflammation
Let-7e Apoptosis Up Mouse serum Yuchuan et al. 2014
miR-19a OncomiR
miR-142 Immunology
miR-191 OncomiR
miR-350 Unknown
Abbreviations: oncomiR, miR with oncogenic properties; ROS, reactive oxygen species; suppressomiR, tumor suppresor 
miR. 
Table 4. Human studies on the effects of exposure to smoking on differential miRNA expression.
miRNA miR function Regulation Tissue/cell type Source
miR-16 p53, cell cycle, JAK/STAT signaling Down Placenta Maccani et al. 2010
miR-21 Fatty acid synthesis, apoptosis
miR-146a Inflammation, NFκβ mediator
miR-223 Immunology Up Maternal and cord blood Herberth et al. 2013
miR-129 Cell cycle regulation, apoptosis Down Spermatozoa Marczylo et al. 2012
miR-634 Inflammation
miR-340 Cell migration and invasion Up Spermatozoa Marczylo et al. 2012
miR-365 Targets NKX2.1
miR-143 Cardiogenesis Down Gastric tissue Stánitz et al. 2013
miR-21 Fatty acid biosynthesis, apoptosis Up Gastric tissue Stánitz et al. 2013
Let-7c Cell proliferation, angiogenesis Down Induced sputum Van Pottelberge et al. 
2011miR-146a Inflammation, NFκβ mediator
miR-150 Hematopoeiesis
miR-203 DNA damage response
miR-340 Cell migration and invasion
miR-443 Unknown
miR-223 Immunology Down Plasma MV Badrnya et al. 2014
miR-29b Apoptosis Up Plasma MV Badrnya et al. 2014
RNU6-2 Reference miR
MV, microvesicles. 
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response to smoking have also been identi-
fied as down-regulated in lung (Takamizawa 
et al. 2004), pancreatic (Vogt et al. 2011), 
and stomach (Rahman et al. 2009) cancer. 
Development of cardio vascular disease is asso-
ciated with up-regulation of miR-206 (Shan 
et al. 2009), and this miRNA has significantly 
higher expression levels in smokers than in 
non smokers. Furthermore, two miRNAs 
that are frequently down-regulated in asso-
ciation with cigarette smoke (i.e., miR-21 
and miR-146a) have lower expression levels 
in individuals with type 2 diabetes compared 
with healthy controls (Zampetaki et al. 
2010). Therefore, these miRNAs could 
support the observation that smoking is an 
independent risk factor for type 2 diabetes 
(Cho et al. 2009). Human studies concerning 
smoking-induced changes of miRNA expres-
sion are summarized in Table 4. Figure 3 is 
a Venn diagram displaying the common and 
distinct miRNAs from in vitro, in vivo, and 
human studies on smoking-induced miRNA 
alterations. miR-125b and miR-21, identified 
in in vivo and human studies, respectively, 
were also reported in in vitro studies. 
Furthermore, several miRNAs were identi-
fied in multiple studies, such as miR-34b 
and miR-146a.
Table 1 summarizes miRNAs with altered 
expression in response to environ mental 
and/or personal exposures reported in at least 
two independent studies, along with their 
known roles in disease etiology. miRNAs 
observed in association with either environ-
mental or personal exposures are often associ-
ated with cancer; in particular, breast and lung 
cancer and leukemia have been frequently 
reported (Table 1). Furthermore, many aber-
rations in the cardio vascular system have 
been reported, such as hypertension, heart 
failure, myocardial infarct, and atherosclerosis. 
Exposures such as air pollution and smoking 
can cause cardio vascular disease and cancer 
(Pope et al. 2011); however, the data shown in 
Table 1 indicate that the listed miRNAs play 
a causative role in disease etiology, rather than 
being merely a marker of exposure. 
Air pollution exposure and miRNA 
expression. Particulate matter (PM) is a 
complex mixture of small particles and liquid 
droplets. Particle pollution is made up of 
a number of components, including acids, 
organic chemicals, metals, and soil or dust 
particles. The size of particles is directly linked 
to their potential to cause health problems 
(Brunekreef and Holgate 2002). Although 
the clinical effects of PM exposure are 
obvious, the under lying mechanism of disease 
initiation and progression is less well under-
stood. miRNAs play a pivotal role in main-
taining healthy lungs (Nana-Sinkam et al. 
2009). Because the lungs are an important 
target site for PM, we suggest that miRNAs 
could underlie the observed health effects of 
PM exposure. In vitro studies on air pollution 
and miRNAs are summarized in Table 5.
In a cohort study of steel plant workers, 
Bollati et al. (2010) examined the effect of 
PM exposure on miRNA expression. Blood 
samples were collected at the beginning of the 
working week (“pre exposure”) and at the end 
of the working week (“post exposure”). PM 
mass and metal components measured in the 
plant were correlated with miRNA expression 
analyses of blood samples. Urinary 8-hydroxy-
2´-deoxyguanosine (8-OH-dG) levels were 
measured as a readout of oxidative stress. 
Both miR-222 and miR-21 were signifi-
cantly increased in post- versus pre exposure 
samples, and only miR-21 expression levels 
were positively correlated with 8-OH-dG 
(Bollati et al. 2010). Oxidative stress has been 
reported to induce miR-21 expression (Cheng 
Figure 3. Venn diagram displaying common and distinct microRNAs associated with smoking in in vitro, 
in vivo, and human studies. miRNAs in bold type were identified in more than one study included in this 
meta-analysis.
Let-7c
miR-16
miR-29b
miR-129
miR-146a
miR-150
miR-203
miR-223
miR-340
miR-365
miR-443
miR-634
Human studies
miR-15a
miR-31
miR-199b
miR-218
miR-452
Let-7a
Let-7b
Let-7e
Let-7f
miR-19a
miR-20b
miR-26a
miR-30b
miR-30c
miR-30e
miR-34b
miR-92b
miR-99b
miR-122a
miR-125b
miR-124a
miR-125a
miR-125b
miR-128
miR-133b
miR-135b
miR-140
miR-142
miR-191
miR-192
miR-206
miR-350
miR-421
miR-431
miR-450b
miR-466
miR-469
miR-668
miR-700
In vitro studies
In vivo studies
miR-21
Table 5. In vitro studies on air pollution–induced changes in miRNA expression.
miRNA miR function Regulation Tissue/cell type Pollutant Source
miR-26b Wnt, p53, autophagy, TGF-β Down Primary human bronchial 
epithelial cells
10 μg/cm2 DEP Jardim et al. 
2009miR-27a Apoptosis, ERα
miR-31 Apoptosis, tumor supressor
miR-96 Several unrelated targets
miR-135b Inflammation, oxidative stress
miR-374a Targets DICER, ATM
miR-513c No validated targets Up Primary human bronchial 
epithelial cells
10 μg/cm2 DEP Jardim et al. 
2009miR-513b No validated targets
miR-513a-5p Targets CD274, immunology
miR-923 Fragment of 28S RNA
miR-494 Targets PTEN
miR-338-5p ABC transporters, endocytosis
miR-10b Angiogenesis Down Human A549 lung 
carcinoma cell line
1 ppm CH2O Rager et al. 
2011miR-181a Apoptosis, oncomiR
miR-330 Targets E2F1, VEGFa, NTRK3
miR-338-5p ABC transporters, endocytosis
miR-375 Immunology Up Human bronchial 
epithelial cells
3 μg/cm2 DEP Bleck et al. 
2013
miR-149 Immunology Down Monkey airway epithelial 
cells
Ozone Clay et al. 
2014
miR-128 Apoptosis Up Human A549 lung 
carcinoma cell line
PM10 Motta et al. 
2013
Abbreviations: CH2O, formaldehyde; DEP, diesel exhaust particles; OncomiR, miR with oncogenic properties. 
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et al. 2009); thus, the association between 
8-OH-dG and miR-21 might simply reflect 
the response of miR-21 to production of 
reactive oxygen species (ROS) in the blood 
due to the PM-induced increase in oxidative 
stress (Bollati et al. 2010) (Table 6).
The cardiovascular anomalies observed in 
association with air pollution exposure have 
often been attributed to the generation of 
oxidative stress (Miller et al. 2012). MiR-21 
is up-regulated in response to diesel exhaust 
particles and metal-rich PM (Bollati et al. 
2010; Bourdon et al. 2012) and is highly 
expressed in the cardiovascular system, 
where it plays an important role in vascular 
cell proliferation and apoptosis and disease 
[reviewed by Cheng and Zhang (2010)]. 
Therefore, miR-21 expression could be an 
important mechanistic link explaining the 
association between air pollution exposure 
and cardio vascular disease.
Levänen et al. (2013) observed distinct 
miRNA expression profiles in patients with 
asthma compared with controls after subway 
exposure. Current epidemiological studies have 
identified the first miRNAs associated with 
air pollution exposure, and provide a list of 
putative biomarkers. Table 6 summarizes the 
human studies on air pollution and miRNAs. 
A Venn diagram displays the common and 
distinct miRNAs from in vitro and human 
studies on air pollution–induced miRNA 
altera tions (Figure 4). The only miRNAs 
identified in both in vitro and human studies 
in association with air pollution exposure 
are miR-10b and miR-128. Furthermore, 
miRNAs -9, -21, -143, -155, -222, -223, and 
-338 were identified in at least two indepen-
dent studies on air pollution and miRNA.
Nanoparticles. Nanoparticles are emitted 
from natural and anthropogenic sources 
and are produced via nanotechnology. 
Fast propagation of nano technologies into 
different industries and consumer products is 
causing exponential growth of nano material 
production. Hence, increasing amounts of 
nano particles reach occupational settings and 
the indoor and outdoor environments, thus 
representing a potentially serious hazard to 
human health (Castranova 2011; Nel et al. 
2006). Nanoparticles are also able to cross 
cell membranes, and their inter actions with 
biological systems are relatively unknown 
(Holsapple et al. 2005). Table 7 includes 
the studies on nanoparticle-induced changes 
in miRNA expression, all of which were 
performed in animal models.
Chemical exposure-induced changes in 
miRNA. Formaldehyde. Formaldehyde is 
an air toxic present in the atmosphere due to 
emission from anthropogenic and biogenic 
sources. Ninety-five percent of inhaled formal-
dehyde is absorbed within the respiratory tract 
(Overton et al. 2001). Formaldehyde has been 
reported to change gene expression patterns in 
nasal and lung cells (Kim et al. 2002; Li et al. 
2007). The miRNAs reported to be down-
regulated in association with formaldehyde 
exposure have been reported to be involved 
in the development of diverse tumors (e.g., 
breast and gastro intestinal cancer, melanoma) 
as well as heart failure (Table 1). Given the 
Table 6. Human studies on air pollution–induced changes in miRNA expression.
miRNA miR function Regulation Tissue/cell type Pollutant Source
miR-21 Fatty acid synthesis, apoptosis Up Peripheral blood 300 μg PM2.5/m3 
DEP
Yamamoto et al. 
2013miR-30e Targets UBC9, MUC17
miR-144 Targets Klfd, FGG, PLAG1
miR-215 Cell cycle, p53 activation
miR-21 Fatty acid synthesis, apoptosis Up Blood leukocytes Metal-rich PM Bollati et al. 2010
miR-222 Cell cycle regulation
miR-375 Immunology Up Bronchial epithelial 
cells
3 μg/cm2 DEP Bleck et al. 2013
miR-34a Cardiogenesis Up Gastric tissue Urban living Stánitz et al. 
2013miR-143 Cardiogenesis
miR-10b Angiogenesis Up Spermatozoa Metal-rich PM Li et al. 2012a
miR-33b Lipid metabolism
miR-106a OncomiR
miR-155 Inflammation
miR-183 OncomiR
miR-205 OncomiR
miR-208a Cardiac hypertrophy
miR-222 Cell cycle regulation
miR-223 Immunology
Let-7d Proliferation, angiogenesis Down Spermatozoa Metal-rich PM Li et al. 2012a
miR-363 DNA damage response
miR-25 DNA damage response Up Induced sputum Ozone Fry et al. 2014
miR-132 Angiogenesis
miR-143 Cardiogenesis
miR-145 Tumor suppressor
miR-199a Oncogene activation
miR-199b Oncogene activation
miR-222 Cell cycle regulation
miR-223 Immunology
miR-424 Angiogenesis
miR-582 Antiapoptosis
miR-1 Apoptosis Down Leukocytes PM2.5, black 
carbon, organic 
carbon, sulfate 
Fossati et al. 
2014miR-9 Neuronal differentiation
miR-21 Fatty acid synthesis, apoptosis
miR-126 Angiogenesis
miR-135a Inflammation
miR-146a Inflammation, NFκβ mediator
miR-155 Inflammation
miR-222 Cell cycle regulation
miR-128 Apoptosis Up Plasma MV PM10 Motta et al. 2013
Abbreviations: DEP, diesel exhaust particles; MV, microvesicles; OncomiR, miR with oncogenic properties; PM2.5, 
particulate matter ≤ 2.5 μm in aerodynamic diameter. 
Figure 4. Venn diagram displaying common and distinct microRNAs associated with air pollution exposure 
in in vitro and human studies. miRNAs in bold type were identified in more than one study included in this 
meta-analysis.
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capability of formaldehyde to pass deep into 
lung tissue and enter systemic circulation, the 
link with cardio vascular disease and cancer has 
been widely discussed [reviewed by Kim KH 
et al. (2011)]. Interestingly, miR-181a, one of 
the miRNAs down-regulated after formalde-
hyde exposure, was reported to affect the DNA 
damage response in breast cancer, enabling 
the identification of aggressive breast tumors 
based on increased miR-181a expression (Bisso 
et al. 2013).
Endocrine disruptors. Organochlorine 
pesticides and plasticizing agents are ubiq-
uitous environmental endocrine-disrupting 
compounds that impact human health 
(Rubin 2011). Bisphenol A (BPA) is an 
industrial plasticizer often used as a coating 
in food cans and in plastic bottles (Kang et al. 
2006). Dichlorodiphenyltrichloroethane 
(DDT) is a well-known organochlorine 
pesticide. Because DDT is very persistent in 
the environment, accumulates in fatty tissues, 
and can travel long distances in the upper 
atmosphere, residues from historical use 
remain a current threat to human health.
DDT and BPA have been reported to 
interfere with endogenous estrogens and 
thyroid hormone, leading to aberra tions 
of the reproductive, immune, and central 
nervous systems (Chevrier et al. 2013; Liu 
et al. 2013). DDT (Waliszewski et al. 2001) 
and BPA (Takahashi and Oishi 2000) cross 
the placental barrier and can induce in utero 
effects that could lead to detrimental effects 
later in life.
Soto et al. (2013) reported that prenatal 
exposure to BPA can alter mammary develop-
ment and lead to breast cancer in humans. 
From a clinical perspective, it is interesting 
that decreased expression of let‑7f has been 
associated with increased breast cancer risk 
(Sakurai et al. 2012), and treatment of 
MCF-7 breast cancer cells with BPA resulted 
in reduced let‑7f expression (Tilghman 
et al. 2012). Furthermore, miR-146a has 
been proposed to induce an Alzheimer’s 
disease pathway (Jiang et al. 2013) and is 
up-regulated after BPA exposure (Table 1). 
Therefore, the neuro degenerative conse-
quences of BPA exposure could at least 
partially be attributed to miR-146a. In vitro 
studies could provide researchers with inter-
esting miRNAs that have potential to be used 
as biomarkers for chemical exposure.
Polychlorinated biphenyls (PCBs) were 
widely used organic chemicals until their 
production was banned because of environ-
mental concerns (Porta and Zumeta 2002). 
PCBs are stable compounds that bioaccu-
mulate in fatty tissues (Steele et al. 1986); 
they have been reported to cause systemic 
changes in gene expression (Ceccatelli et al. 
2006), suggesting that miRNA regulation 
could be involved in this process. Tsukimori 
Table 8. In vitro studies on chemically induced changes in miRNA expression.
miRNA miR function Regulation Tissue/cell type Chemical Source
let-7g Cell proliferation, angiogenesis Down MCF-7 cells BPA Tilghman et al. 2012
let-7f Cell proliferation, angiogenesis
miR-21 Fatty acid biosynthesis, apoptosis
miR-26b Wnt, p53, autophagy, TGF-β
miR-342-3p Tumor suppressomiR
miR-15b Tumor suppressor targeting BCL2 Down MCF-7 cells BPA, DDT Tilghman et al. 2012
miR-222 Cell cycle regulation Up MCF-7 cells BPA Tilghman et al. 2012
miR-638 No known function Up MCF-7 cells BPA, DDT Tilghman et al. 2012
miR-663 Immunology, oxidative stress Down MCF-7 cells DDT Tilghman et al. 2012
miR-1915 No known function
miR-27b Angiogenesis
miR-92a Tumor supressomiR 
miR-92b Tumor supressomiR 
miR-1308 No known function Up MCF-7 cells DDT Tilghman et al. 2012
miR-146a Inflammation, NFκβ mediator Up Human placental 
cell lines
BPA Avissar-Whiting 
et al. 2010
miR-150 Hematopoeiesis Down Jurkat T cell line Arsenic Sturchio et al. 2014
miR-30d Autophagy Up Jurkat T cell line Arsenic Sturchio et al. 2014
miR-142 Immunology
miR-181a Apoptosis, oncomiR
miR-221 DNA damage response
miR-222 Cell cycle regulation
miR-638 No known function
miR-663 Immunology, oxidative stress
miR-190 OncomiR Up Human bronchial 
epithelial cells
Arsenic Beezhold et al. 2011
miR-19b OncomiR Up HUVEC cells Arsenic Li et al. 2012b
miR-21 Fatty acid biosynthesis, apoptosis
miR-24 OncomiR
miR-29b Apoptosis
miR-33a Lipid metabolism
miR-198 Cell proliferation
miR-508-5p Cell invasion and migration
miR-1252 No known function
miR-181a Apoptosis, oncomiR Up HepG2 cells PAH Song et al. 2013
miR-181b Apoptosis, oncomiR
miR-181d Apoptosis, oncomiR
Abbreviations: BPA, bisphenol A; DDT, dichlorodiphenyltrichloroethane; OncomiR, miR with oncogenic properties; PAH, 
polycyclic aromatic hydrocarbon; tumor suppressomiR, tumor suppressor miR. 
Table 7. Studies on nanoparticle-induced changes in miRNA expression.
miRNA miR function Regulation Pollutant Source
miR-21 Fatty acid synthesis, apoptosis Up 0.268 or 0.162 mg carbon black NP Bourdon et al. 2012
miR-135b Inflammation, oxidative stress
miR-146 Inflammation, NFκβ mediator
miR-122 Stress response Up 70 nm in silica NP Nagano et al. 2013
miR-192 Oncogene activation
Let-7a Cell proliferation, angiogenesis Up 100 nm gold NP Balansky et al. 2013
miR-183 OncomiR
Abbreviations: NP, nanoparticles; oncomiR, miR with oncogenic properties. 
Figure 5. Venn diagram displaying common and distinct microRNAs associated with arsenic exposure in 
in vitro and human studies. miRNAs in bold type were identified in more than one study included in this 
meta-analysis.
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et al. (2008) reported an association between 
maternal PCB exposure and fetal toxicity, 
impaired fetal growth, and pregnancy loss. 
2,3,7,8-Tetrachlorodibenzo-p-dioxin 
(TCDD) has been reported to adversely affect 
the immune system in rats (Faith and Luster 
1979). In addition, Camacho et al. (2004) 
reported that TCDD exposure of pregnant 
mice affected the immune system of fetuses 
by suppressing T-cell function. Given the 
regulatory role miRNAs play in the immune 
system (Contreras and Rao 2012), it can be 
expected that miRNAs are important in regu-
lating the detrimental health effects observed 
after exposure to TCDD and PCBs.
Arsenic. Environmental exposure to 
arsenic, especially to trivalent inorganic arsenic 
(As3+), is a health concern given the high 
concentrations present in groundwater across 
the world (Fendorf et al. 2010). Exposure to 
arsenic has been associated with increased risk 
of cancer due to genomic instability (Dulout 
et al. 1996), and long-term arsenic exposure 
has been observed to induce peripheral vascular 
injury (Tseng 2008). A Venn diagram showing 
the common and distinct miRNAs from 
in vitro and human studies on arsenic-induced 
miRNA alterations is presented in Figure 5. 
Only miRNA-21 was associated with arsenic 
exposure in in vitro model systems and in 
human studies. Three miRNAs were identified 
by at least two independent studies on arsenic 
exposure and miRNA expression, namely, 
miR-26b, miR-181a, and miR-222.
Aluminum sulfates. Aluminum is the 
most widely distributed metal in the environ-
ment and is extensively used in daily life. 
Chronic exposure of animals to aluminum 
is associated with behavioral and neuro-
pathological changes (Fulgenzi et al. 2014). 
Epidemiological studies have shown poor 
performance in cognitive tests and a higher 
abundance of neurological symptoms in 
workers occupationally exposed to aluminum 
(Kumar and Gill 2009).
Hexahydro-1,3,5-trinitro-s-triazine 
(RDX). The polynitramine explosive RDX is a 
heavily used second-generation high explosive, 
and its use can result in the contamination of 
soils, sediments, and water (Davis et al. 2004). 
RDX exposure has been reported to be toxic to 
the neural and immune systems and to increase 
tumor incidence in several cancers (Garcia-
Reyero et al. 2011; Sweeney et al. 2012). 
Diethylstilbestrol (DES). The synthetic 
estrogen DES was prescribed to pregnant 
women from the 1940s to the 1960s in order 
to prevent mis carriages; however, DES was 
later reported to be responsible for increasing 
breast cancer in the mothers and gynecologic 
tumor incidence in their exposed daughters 
(Greenberg et al. 1984; Mittendorf 1995). 
Perf luorooctanoic  ac id  (PFOA) . 
Perfluoroalkyl chemicals (PFCs) are highly 
stable and widely used in industrialized 
countries. PFCs are both lipophobic and 
hydrophobic; thus, after absorption they will 
bind to proteins in serum and liver rather 
than accumulate in lipids. PFOA is one of the 
most commonly used PFCs. 
The studies we reviewed on chemical-
induced changes in miRNA expression are 
summarized in Tables 8–10 by type of study: 
in vitro (Table 8), in vivo (Table 9), and 
human (Table 10) studies.
Conclusions
miRNAs are omnipresent in the genome and 
are important regulators of gene expression 
in response to intra cellular as well as environ-
mental cues. In this review, we examined 
the response of the miRNA machinery to 
personal and environmental exposures, 
including air pollution, cigarette smoking, 
and chemicals such as endocrine disruptors. 
miRNAs have been proposed as biomarkers 
for disease; however, the literature also reveals 
their potential to be used as biomarkers of 
environ mental exposure.
In different studies on the same environ-
mental pollutant, overall the identified 
miRNAs showed similar patterns of expres-
sion regulation. In studies where smoking-
induced changes were investigated, the 
general observation was a down-regulation 
of expression. For example, miR-125b was 
down-regulated in response to cigarette 
smoke in both primary human bronchial 
epithelial cells (Schembri et al. 2009) and 
mouse lung tissue (Izzotti et al. 2009). 
However, when unique miRNAs had altered 
expression patterns in response to different 
Table 9. In vivo studies on chemically induced changes in miRNA expression.
miRNA miR function Regulation Tissue/cell type Chemical Source
let-7e Apoptosis Down Fetal mouse 
thymocytes
TCDD Singh et al. 2012
miR-18b Apoptosis
miR-23a Apoptosis
miR-23b Apoptosis
miR-27a Apoptosis, ERα
miR-28 Apoptosis
miR-29a Apoptosis
miR-31 Apoptosis, tumor supressomiR
miR-98 Apoptosis
miR-101b Apoptosis
miR-181c Apoptosis, oncomiR
miR-182 Apoptosis
miR-200a Apoptosis, cell cycle, MAPK
miR-23 Apoptosis
miR-290 Apoptosis
miR-335 Apoptosis
miR-491 Apoptosis, targets BCL-XL
miR-122 Stress response Up Fetal mouse 
thymocytes
TCDD Singh et al. 2012
miR-181a OncomiR
miR-125b Targets p53, stress response Up Monkey nasal 
epithelium
Formaldehyde Rager et al. 2013
miR-152 Tumor suppressor, methylation
miR-219 NMDA receptor signaling
miR-532 Unknown
miR-22 PTEN, AKT signaling Down Monkey nasal 
epithelium
Formaldehyde Rager et al. 2013
miR-26b Wnt, p53, autophagy, TGF-β
miR-29a Apoptosis
miR-140 p53 effector
miR-142 Immunology
miR-145 Tumor suppressor, stem cell different
miR-203 DNA damage response
miR-374a Targets DICER, ATM
miR-520f Unknown
miR-27a Apoptosis, ERα Down Mouse brain 
and liver
RDX Zhang and Pan 
2009miR-200c Apoptosis
let7-e Apoptosis
miR-206 Targets SERP1, BDNF, FOXP1
miR-451 Targets PI3K/AKT Down Rat liver PFOS Wang et al. 2014
miR-23a Apoptosis Up Rat liver PFOS Wang et al. 2014
miR-25 DNA damage response
miR-125a Oncogene activation, ROS
miR-133a Smooth muscle differentiation
miR-133b Targets LAG1 and PTBP2
miR-206 Targets SERP1, BDNF, FOXP1
miR-494 Targets PTEN
miR-542 DNA damage response
Abbreviations: OncomiR, miR with oncogenic properties; PFOS, perfluorooctane sulfonate; RDX, hexahydro-1,3,5-trinitro-
s-triazine; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin. 
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environmental exposures, their direction 
of regulation could be the same (10/25 
miRNAs) or the opposite (15/25 miRNAs; 
60%). The different exposures we discussed 
here have their own unique health effects, so 
one would not expect them to have the same 
effect on the miRNA machinery. However, 
there is sometimes a discrepancy when 
looking at the same exposure indicator; for 
example, in response to smoking, miR-21 
has been reported to be up-regulated in 
some studies and down-regulated in others 
(Table 4). Part of the discrepancy can be 
explained by the different exposure models 
that were used.
In general, different in vitro studies 
show little overlap, potentially because of 
the complex miRNA–mRNA networks that 
underlie the observations and the differences 
in exposure used across studies. In studies of 
the same environmental pollutant in vitro, 
in vivo, or in humans, identified miRNAs 
were quite distinct (Figures 3–5). This can 
be explained in part by the observation that 
animal models do not always reflect genomic 
responses that occur in humans (Seok et al. 
2013). Discrepancy between different studies 
might also stem from differences in exposure 
duration. For example, in a study in rats, the 
duration of exposure uniquely influenced 
expression patterns of the individual miRNAs 
(Izzotti et al. 2011).
Human epidemiological studies are 
necessary to observe exposure-related effects 
on miRNAs. Understanding the exposome 
requires putting together pieces of a complex 
puzzle. Epidemiological studies need input 
from experimental studies to identify good 
candidate biomarkers, and results from epide-
miological studies often need follow-up by 
experimental studies to investigate mecha-
nisms of action and to study tissue depen-
dency of effects because human studies are 
most often performed in easily accessible 
tissues such as blood and saliva as a surrogate 
for the actual target tissues. 
Currently, epidemiological studies on 
microRNA often involve free or exosomal 
miRNAs present in saliva or other body 
fluids. However, it is not clear whether these 
observed miRNA changes are a true reflection 
of the body’s response and can really predict 
health effects. In blood, miRNAs within the 
exosomes have been shown to overlap with 
cellular miRNA profiles: Cheng et al. (2014) 
observed that exosomes derived from blood 
were enriched for miRNAs and that miRNA 
profiles between blood cells and the cell-free 
exosomal fraction showed important overlap. 
Because miRNAs can regulate mRNA 
expression in both a negative manner and 
a positive manner (Vasudevan et al. 2007) 
and because many miRNAs can bind the 
same mRNA (Saetrom et al. 2007), it is 
difficult to draw conclusions from miRNA 
studies without infomation on the concur-
rent mRNA(s) expression pattern. However, 
this information is rare in current reports 
on epidemiological studies of miRNAs. The 
findings of this review underscore the complex 
networks that are built by miRNAs and the 
mRNAs they regulate because one miRNA 
can influence many mRNAs according to the 
timing and pattern of expression. 
Many of the reviewed studies used large-
scale micro array profiling, but follow-up and 
validation with more quantitative approaches 
often lags behind. This delay is understand-
able because of the cost and labor intensity 
inherent to these techniques; however, it is 
important to confirm the miRNAs that are 
responsive to environmental exposures. 
Researchers are currently publishing exten-
sive lists of miRNAs that are responsive to envi-
ronmental exposures and showing their utility 
as biomarkers of effect. Future research should 
focus on identifying the molecular mechanism 
behind miRNA expression changes in response 
to exposure to determine whether the changes 
in miRNA expression are merely a symptom of 
the (patho)physiological processes the organism 
undergoes after exposure, or whether miRNAs 
are the drivers responsible for these changes. 
Izzotti and Pulliero (2014) recently reviewed 
the putative mechanisms of action behind 
miRNAs’ response to environmental exposure. 
However, the effect of the identified miRNAs 
on putative mRNA targets should also be 
studied to determine whether the change in 
miRNA expression has functional consequences 
and which mRNAs are true miRNA targets 
under the given circumstances. 
At present, little is known about whether 
environmental exposures induce long-term 
changes in human miRNA expression or 
whether these have a transient character. 
To address this problem, more longitudinal 
studies should be conducted to examine the 
long-term effects of exposure. Results from 
animal studies suggest that miRNA expres-
sion changes in response to formaldehyde 
exposure are transient and revert to normal 
levels after recovery from exposure (Rager 
et al. 2014), but Izzotti et al. (2011) reported 
that miRNA profiles in target organs did 
not recover 1 week after cessation of long-
term cigarette smoke exposure. In a study in 
humans, Takahashi et al. (2013) observed 
that miRNA expression profiles of indi-
viduals who quit smoking resembled those 
of non smokers. 
Follow-up in future generations is 
necessary to determine the heritability of 
the miRNA expression changes. It would 
be very interesting to examine the effect 
of in utero environmental exposures on 
develop ment of disease in later life and the 
role miRNAs play in inducing these health 
effects. Furthermore, long-term longitudinal 
studies would allow us to distinguish between 
cause and effect of miRNA expression and 
environ mental exposure, and would also allow 
us to estimate the contribution of miRNAs 
to disease development. Studies have shown 
that miRNAs can be used as biomarkers of 
disease as well as biomarkers for environ-
mental exposure and that miRNAs hold great 
potential to explain disease etiology. 
Table 10. Human studies on chemically induced changes in miRNA expression.
miRNA miR function Regulation Tissue/cell type Chemical Source
miR-191 OncomiR Up Peripheral blood PCB-169 Guida et al. 2013
miR-146a Inflammation, NFκβ mediator Up Fetal brain cells Aluminum Pogue et al. 2009
miR-9 Neuronal differentiation
miR-125b Targets p53, stress response Up Fetal brain cells Aluminum Lukiw and Pogue 2007
miR-128 Apoptosis
miR-199a Oncogene activation Up Serum PFOA Wang J et al. 2012
miR-21 Fatty acid biosynthesis, apoptosis Up Blood samples Arsenic Kong et al. 2012
miR-26b Wnt, p53, autophagy, TGF-β
Let-7a Cell proliferation, angiogenesis Up Cord blood Arsenic Rager et al. 2014
miR-16 p53, cell cycle, JAK/STAT 
miR-17 DNA damage response
miR-20a Angiogenesis
miR-20b Hypoxia
miR-26b Wnt, p53, autophagy, TGF-β
miR-96 Several unrelated targets
miR-98 Apoptosis
miR-107 Targets Notch2
miR-126 Angiogenesis
miR-195 Tumor suppressomiR
miR-454 Unknown
miR-24 OncomiR Down Plasma PAH Deng et al. 2014
miR-27a Apoptosis, ERα
miR-28 Apoptosis
miR-142 Immunology
miR-150 Hematopoeiesis Up Plasma PAH Deng et al. 2014
Abbreviations: OncomiR, miR with oncogenic properties; PAH, polycyclic aromatic hydrocarbon; suppressomiR, 
tumor suppressor miR.
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